Examining Second Generation Cancer Vaccines

Time: 12:00 pm
day: Conference Day One


  • Understanding how the bulk of neoantigens within the exome are SNPs, mostly resulting in single amino acid changes, necessitating the selection of neoantigens predicted to be immunogenic
  • Evaluating how current technology allows fast Whole Genome Sequencing, deep long-read sequencing of intact complete mRNAs, and the bioinformatics capacity to handle this information
  • Examining how using this approach we design vaccines that contain 10-100 times more potentially antigenic neo-antigenic amino acids